Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Michele Falda"'
Autor:
Emilio Paolo Alessandrino, Matteo Giovanni Della Porta, Andrea Bacigalupo, Luca Malcovati, Emanuele Angelucci, Maria Teresa Van Lint, Michele Falda, Francesco Onida, Massimo Bernardi, Stefano Guidi, Barbarella Lucarelli, Alessandro Rambaldi, Raffaella Cerretti, Paola Marenco, Pietro Pioltelli, Cristiana Pascutto, Rosi Oneto, Laura Pirolini, Renato Fanin, Alberto Bosi
Publikováno v:
Haematologica, Vol 95, Iss 3 (2010)
Background Transfusion-dependency affects the natural history of myelodysplastic syndromes. Secondary iron overload may concur to this effect. The relative impact of these factors on the outcome of patients with myelodysplastic syndrome receiving all
Externí odkaz:
https://doaj.org/article/0a1fb56eb86948d2bf56a0a8f3f407f0
Autor:
Bénédicte Bruno, F. Bonifazi, Andrea Bacigalupo, Michele Falda, William Arcese, Attilio Olivieri, Alessandro Rambaldi, Roberto Raimondi, Fabio Ciceri, Roberto M. Lemoli, Giorgina Specchia, Giovanna Meloni, Francesco Onida, Francesco Saraceni, Emilio Paolo Alessandrino, Alberto Bosi, Rosanna Scimè
Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de619c305d4f2473c28afdc09d3ae0e5
http://hdl.handle.net/2108/177677
http://hdl.handle.net/2108/177677
Autor:
Clara Pecoraro, Bernardino Allione, Luisa Giaccone, Chiara Frairia, Alessandro Levis, Massimo Pini, Filippo Marmont, Giovannino Ciccone, Alessandro Busca, Stefano D'Ardia, Benedetto Bruno, Michele Falda, Umberto Vitolo, Maria Teresa Corsetti, Anna Castiglione, Ernesta Audisio
Publikováno v:
Leukemia & Lymphoma. 55:863-869
The aim of the present study was to investigate the outcome of 94 adult patients with myelodysplasia (MDS) who received an allogeneic stem cell transplant between January 1995 and September 2010 in two Italian hematology centers. At the time of trans
Autor:
Francesco Locatelli, Michele Falda, Ilaria Cavecchia, Ileana Baldi, E. Gaido, Roberto Serra, Filippo Marmont, Alessandro Busca, F. G. De Rosa, Stefano D'Ardia, G. Ciccone
Publikováno v:
Transplant Infectious Disease. 14:40-48
Blood stream infections (BSIs) remain one of the major causes of morbidity and mortality for patients receiving an allogeneic hematopoietic stem cell transplantation (HSCT). In the present study, we evaluated the incidence and characteristics of BSI
Autor:
Mario Boccadoro, Vincenzo Squadrone, Carlotta Bagna, Massimo Massaia, Umberto Vitolo, Michele Falda, Filippo Marmont, Arthur S. Slutsky, Stefania Bertone, Benedetto Bruno, Claudia Filippini, V. Marco Ranieri
Publikováno v:
Intensive Care Medicine. 36:1666-1674
Although chemotherapy and transplantation improve outcome of patients with hematological malignancy, complications of these therapies are responsible for a 20–50% mortality rate that increases when respiratory symptoms evolve into acute lung injury
Autor:
Lucia Farina, Samantha Ferrari, Nicola Mordini, Barbara Sarina, Alessandro Levis, Simonetta Viviani, Angelo Michele Carella, Benedetto Bruno, Fabio Ciceri, Armando Santoro, Luca Castagna, Alessandro Bonini, Enrico Morello, Michele Malagola, Giuseppe Milone, Francesca Patriarca, Stefano Guidi, Paolo Corradini, Fabio Benedetti, Laura Giordano, Michele Falda
Publikováno v:
Blood. 115:3671-3677
Hodgkin lymphoma relapsing after autologous transplantation (autoSCT) has a dismal outcome. Allogeneic transplantation (alloSCT) using reduced intensity conditioning (RIC) is a salvage option, but its effectiveness is still unclear. To evaluate the r
Autor:
Filomena Longo, Alessandro Busca, Franco Locatelli, Roberto Calabrese, Sergio D'Antico, Stefano D'Ardia, Adriano Valfrè, Michele Falda, Annalisa Chiappella, Paola Manzini, Antonio Piga
Publikováno v:
Biology of Blood and Marrow Transplantation. 16(1):115-122
Iron overload (IO) is a known adverse prognostic factor in patients who undergo allogeneic hematopoietic stem cell transplantation (HSCT) for thalassemia and appears to play a similar role in patients with other hematologic disorders. The estimation
Autor:
Cristina Grange, Ciro Tetta, Alessandro Busca, Maria Chiara Deregibus, Stefania Bruno, Michele Falda, Silvia Saviozzi, Raffaele A. Calogero, Giovanni Camussi, Federica Collino, Benedetta Bussolati, Laura Morando
Publikováno v:
Journal of the American Society of Nephrology. 20:1053-1067
Administration of mesenchymal stem cells (MSCs) improves the recovery from acute kidney injury (AKI). The mechanism may involve paracrine factors promoting proliferation of surviving intrinsic epithelial cells, but these factors remain unknown. In th
Autor:
Luigi Chiusa, Luigi Resegotti, Achille Pich, Mario Boccadoro, Michele Falda, Filippo Marmont, Franco Locatelli
Publikováno v:
European Journal of Haematology. 56:39-44
The correlation between the bromodeoxiuridine (BrdU)-labelling index (LI) of plasma cells and a new proliferation marker, the Argyrophilic Nucleolar Organizer Regions (AgNORs), was investigated in 44 myeloma patients at diagnosis. A preliminary analy
Autor:
Alessandro Rambaldi, Bénédicte Bruno, Michele Falda, M P Sormani, Francesca Bonifazi, Simona Pollichieni, Almalina Bacigalupo, Alberto Bosi, P E Alessandrino, Giuseppe Bandini, Roberto Crocchiolo, Katharina Fleischhauer, R Fanin, Nicoletta Sacchi, Fabio Ciceri, Rosi Oneto
Publikováno v:
Bone Marrow Transplantation. 44:571-577
The importance of HLA donor-recipient matching in unrelated haematopoietic SCT (HSCT) is the subject of debate. In this retrospective study, we analyzed 805 adult patients from the Italian Registry receiving HSCT for a haematological malignancy from